Thursday, May 23, 2024
HomeTagsHuntington Disease

Huntington Disease

Neurocrine Biosciences Announces U.S. FDA Accepts Supplemental New Drug Application

Neurocrine Biosciences, Inc., a leading neuroscience-focused biopharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) has accepted its supplemental New Drug Application...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics